Galafold 123 MG
Ended Awarded Last action
- Contract number
- 36C24526N0476
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $22,840
Award facts
- Contract value 100% obligated
- $22,839.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
Veterans Integrated Service Network 5 issued a $22,839.61 delivery order to Amicus Therapeutics US, LLC on April 7, 2026, for Galafold 123 mg under the GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB).
The parent contract is a multiple-award Federal Supply Schedule vehicle (36F79724D0185) valued at $13.024 million, effective through August 31, 2029, enabling VA medical centers nationwide to procure specialized pharmaceutical products. Place of performance is Philadelphia, PA. The order is firm fixed price with no set-aside applied and an ultimate completion date of April 10, 2026. Galafold (migalastat) 123 mg is an FDA-approved enzyme replacement therapy for Fabry disease treatment in the veteran population. Amicus Therapeutics US, LLC serves as the prime contractor with no subcontractor involvement.
Quick answers
Who was awarded contract 36C24526N0476?
36C24526N0476 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 7, 2026.
How much is contract 36C24526N0476 worth?
The government has obligated $22,840 on 36C24526N0476.
Is contract 36C24526N0476 an order under another contract?
Yes. 36C24526N0476 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0476 competed?
The extent of competition for 36C24526N0476 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award